Exponent (EXPO) – Analysts’ Recent Ratings Updates

Exponent (NASDAQ: EXPO) recently received a number of ratings updates from brokerages and research firms:

  • 8/1/2019 – Exponent was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating.
  • 8/1/2019 – Exponent was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating.
  • 7/22/2019 – Exponent was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “strong-buy” rating. They now have a $76.00 price target on the stock. According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. “
  • 7/19/2019 – Exponent had its price target raised by analysts at Cantor Fitzgerald from $64.00 to $73.00. They now have an “overweight” rating on the stock.
  • 7/19/2019 – Exponent was given a new $70.00 price target on by analysts at SunTrust Banks, Inc.. They now have a “buy” rating on the stock.
  • 7/17/2019 – Exponent was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 7/16/2019 – Exponent was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. “
  • 7/15/2019 – Exponent was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $67.00 price target on the stock. According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. “
  • 7/9/2019 – Exponent was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 6/24/2019 – Exponent was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. “
  • 6/11/2019 – Exponent was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.

EXPO traded down $0.75 during trading on Friday, reaching $67.32. 323,314 shares of the company’s stock were exchanged, compared to its average volume of 204,190. The firm has a fifty day moving average of $61.42. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.60 and a quick ratio of 4.22. Exponent, Inc. has a fifty-two week low of $44.44 and a fifty-two week high of $70.19. The firm has a market cap of $3.57 billion, a price-to-earnings ratio of 53.86 and a beta of 0.44.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Thursday, July 18th. The business services provider reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.06. The company had revenue of $106.50 million for the quarter, compared to analysts’ expectations of $95.77 million. Exponent had a net margin of 19.64% and a return on equity of 23.44%. The business’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same period last year, the firm posted $0.34 earnings per share. Equities research analysts forecast that Exponent, Inc. will post 1.47 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 20th. Stockholders of record on Friday, September 6th will be given a dividend of $0.16 per share. The ex-dividend date is Thursday, September 5th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.95%. Exponent’s dividend payout ratio is 51.20%.

In other news, Director Carol Lindstrom sold 1,800 shares of Exponent stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $56.92, for a total transaction of $102,456.00. Following the transaction, the director now directly owns 3,212 shares of the company’s stock, valued at $182,827.04. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 2.30% of the company’s stock.

Large investors have recently modified their holdings of the business. Bremer Bank National Association bought a new stake in Exponent during the 1st quarter worth about $55,000. Quadrant Capital Group LLC lifted its position in Exponent by 961.2% during the 1st quarter. Quadrant Capital Group LLC now owns 1,040 shares of the business services provider’s stock worth $57,000 after buying an additional 942 shares in the last quarter. Ellis Investment Partners LLC bought a new stake in Exponent during the 1st quarter worth about $90,000. NN Investment Partners Holdings N.V. bought a new stake in Exponent during the 2nd quarter worth about $91,000. Finally, Cim LLC bought a new stake in Exponent during the 2nd quarter worth about $200,000. 88.16% of the stock is currently owned by hedge funds and other institutional investors.

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

See Also: Blockchain

Receive News & Ratings for Exponent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc and related companies with MarketBeat.com's FREE daily email newsletter.